← Leaderboards
Antonio Luigi Amelio
Scripps Florida
$4,949,914
Attributed
$6,231,770
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,231,770 · 6
By mechanism
R01$2,479,061 · 1
U01$2,145,712 · 1
R00$739,531 · 1
R21$418,000 · 1
K99$294,300 · 1
F32$155,166 · 1
Top collaborators
- Anna R Giuliano3 shared
- Scott E Williams2 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsGenesTumorTumorigenesisMediatingInnovationIn VivoOncogenesGeneticLinkCause Of DeathMolecularTranscription CoactivatorUnited StatesCreb1 GeneCharacteristicsChromosomal TranslocationEventMouse ModelTranscription FactorComplexInsulin-Like Growth Factor IMll/EllCells
Grant awards (18)
Biomarker Approach to Screening for the early detection of HPV-related Oropharyngeal Cancer (BASH OPC)$715,985
U01 · FY2025 · DE
Role of CRTC1-MAML2 in Salivary Mucoepidermoid Carcinoma Pathobiology$498,468
R01 · FY2025 · DE · contact PI
Biomarker Approach to Screening for the early detection of HPV-related Oropharyngeal Cancer (BASH OPC)$702,649
U01 · FY2024 · DE
Role of CRTC1-MAML2 in Salivary Mucoepidermoid Carcinoma Pathobiology$492,000
R01 · FY2024 · DE · contact PI
Biomarker Approach to Screening for the early detection of HPV-related Oropharyngeal Cancer (BASH OPC)$727,078
U01 · FY2023 · DE
Role of CRTC1-MAML2 in Salivary Mucoepidermoid Carcinoma Pathobiology$499,583
R01 · FY2023 · DE · contact PI
Role of CRTC1-MAML2 in Salivary Mucoepidermoid Carcinoma Pathobiology$495,063
R01 · FY2022 · DE · contact PI
Role of CRTC1-MAML2 in Salivary Mucoepidermoid Carcinoma Pathobiology$493,947
R01 · FY2021 · DE · contact PI
Illuminating the Role of Oral Stem Cells in the Development of Oral Squamous Cell Carcinomas$228,000
R21 · FY2017 · DE
Convergence of CREB and MYC Pathways in Oncogenesis.$249,000
R00 · FY2016 · CA · contact PI
Illuminating the Role of Oral Stem Cells in the Development of Oral Squamous Cell Carcinomas$190,000
R21 · FY2016 · DE
Convergence of CREB and MYC Pathways in Oncogenesis.$249,000
R00 · FY2015 · CA · contact PI
Convergence of CREB and MYC Pathways in Oncogenesis.$241,531
R00 · FY2014 · CA · contact PI
Convergence of CREB and MYC Pathways in Oncogenesis.$147,150
K99 · FY2013 · CA · contact PI
Convergence of CREB and MYC Pathways in Oncogenesis.$147,150
K99 · FY2012 · CA · contact PI
Characterizing the Role of MYC-MAX Complexes in TORC1/MAML2-mediated Oncogenesis$53,810
F32 · FY2010 · CA · contact PI
Characterizing the Role of MYC-MAX Complexes in TORC1/MAML2-mediated Oncogenesis$51,710
F32 · FY2009 · CA · contact PI
Characterizing the Role of MYC-MAX Complexes in TORC1/MAML2-mediated Oncogenesis$49,646
F32 · FY2008 · CA · contact PI